When researchers review a peptide Certificate of Analysis, one number often attracts immediate attention: purity.
A COA might report a result such as 98%, 99%, or even greater than 99% purity. At first glance, that percentage can appear to provide a simple summary of the material in the vial.
But analytical chemistry is rarely that simple.
A reported purity value describes the result of a specific analytical method performed under specific conditions. It does not necessarily mean that the same percentage of the vial's total physical mass consists of the target peptide, nor does a purity result by itself establish molecular identity, peptide content, sterility, endotoxin status, water content, or every other characteristic that may matter in laboratory research.
Understanding a COA therefore requires looking beyond a single percentage and asking a more useful question: What exactly did the analytical method measure?
HPLC Purity: What Is Being Measured?
High-performance liquid chromatography, or HPLC, is one of the most widely used analytical techniques for evaluating synthetic peptides.
During an HPLC analysis, components of a sample are separated according to how they interact with the chromatographic system. The resulting chromatogram displays peaks representing material detected as it exits the column.
For peptide analysis, the target peptide will generally produce a primary chromatographic peak, while additional detectable components may appear as smaller peaks.
A reported chromatographic purity value is commonly calculated from the relative area associated with the target peak compared with the total integrated peak area included in the analysis.
This makes HPLC extremely useful for examining the relative chromatographic composition of a sample and detecting peptide-related impurities or degradation products that can be separated by the method. Chromatographic techniques are therefore central to peptide characterization and quality control. [1]
99% HPLC Purity Does Not Necessarily Mean 99% of the Vial Is Peptide
Suppose an analytical report lists Purity (HPLC): 99.2%. It can be tempting to interpret that result as meaning that 99.2% of everything physically present in the vial is the desired peptide.
That is not necessarily what the measurement says.
Chromatographic purity primarily describes the relative distribution of material detected and integrated by that chromatographic method. A lyophilized peptide preparation can also contain water, counterions, residual substances, or other material whose contribution to total vial mass is not equivalent to the peptide-related chromatographic peak-area calculation.
This is why chromatographic purity and absolute peptide content are distinct analytical concepts.
Methods such as amino-acid analysis can be used for quantitative characterization of synthetic peptides, and combining quantitative methods with chromatography and mass spectrometry provides a more complete picture than any one measurement alone. [3,4,6]
Purity and Identity Are Different Questions
Another important distinction on a COA is the difference between purity and identity.
HPLC asks questions related to separation and chromatographic composition. Mass spectrometry asks a different question.
Mass spectrometry (MS) measures mass-to-charge information from ionized molecules and can provide evidence that the analyzed material has the molecular mass expected for the target peptide. That makes MS particularly valuable for supporting molecular identity and integrity in synthetic peptide characterization. [5]
In simplified terms, HPLC asks how the sample separates chromatographically and what proportion of the detected chromatographic signal is associated with the target peak. Mass spectrometry asks whether the analyzed material produces molecular-mass information consistent with the expected molecule.
Neither measurement simply replaces the other. Together, they provide complementary information.
Why One Large HPLC Peak Is Not the Entire Story
A chromatogram containing one dominant peak is certainly informative, but analytical separation has limitations.
Different compounds can sometimes possess sufficiently similar chromatographic behavior that they are difficult to resolve under a particular method. Researchers studying pharmaceutical peptides have investigated this problem using multidimensional liquid chromatography because structurally related impurities can potentially coelute with a target peptide. [7]
Synthetic peptide impurities can include species resulting from amino-acid substitutions, truncations, degradation, isomerization, or other structural changes. Some of these differences are analytically subtle.
So a purity percentage should always be interpreted in the context of the method used to generate it.
Peptide Content Is Another Measurement
Researchers may also encounter a COA reporting peptide content. That value should not automatically be treated as another name for HPLC purity.
Peptide content attempts to quantify the amount of peptide material present, whereas chromatographic purity describes relative composition according to the chromatographic measurement.
Amino-acid analysis is one established approach for quantitative characterization of synthetic peptides. After hydrolysis, released amino acids can be measured and used to estimate peptide quantity. Modern approaches can also combine amino-acid analysis with liquid chromatography and mass spectrometry. [3,4,6]
The distinction matters because two samples could theoretically display very similar chromatographic purity while differing in absolute peptide content.
A COA Is a Collection of Analytical Questions
A well-designed Certificate of Analysis should be read as a collection of measurements rather than as a single quality score.
Depending on the material and testing program, a COA might contain information related to identity, chromatographic purity, peptide content, water content, endotoxin testing, and sterility or microbiological testing. Each test answers a different analytical question.
Research on peptide reference standards likewise emphasizes that peptide quality characterization relies on multiple analytical tests, including chromatography, mass spectrometry and other quantitative approaches, rather than a single universal measurement. [8]
Lot Numbers Matter Too
Analytical results also belong to the material that was actually tested. That is why lot or batch traceability is an important part of interpreting a COA.
A certificate associated with one production lot should not automatically be assumed to describe every future lot of the same peptide. Matching the lot identifier on the analytical documentation to the corresponding research material helps preserve the connection between the physical sample and the reported analytical results.
How Researchers Should Read a Peptide COA
Instead of looking only for the largest percentage on the page, a more scientifically useful approach is to read the COA method by method.
Ask: What test produced this result? What property was that test designed to measure? Does another analytical method independently support molecular identity? Is peptide content reported separately from chromatographic purity? Which lot was actually tested? Are other relevant analytical results reported separately?
This approach turns the COA from a marketing number into what it should be: analytical documentation describing a specific material through specific measurements.
Purity Is Important—But Context Makes It Meaningful
A high chromatographic purity result can be an important piece of analytical information. But the percentage becomes scientifically meaningful only when the reader understands how it was measured and what the measurement represents.
HPLC can provide powerful information about chromatographic purity and peptide-related impurities. Mass spectrometry can provide complementary evidence supporting molecular identity. Quantitative techniques can address peptide content, while additional assays can evaluate other material characteristics.
The strongest interpretation therefore does not come from asking, “What is the purity percentage?” It comes from asking, “What analytical evidence supports our understanding of this material?”
That distinction is fundamental to responsible peptide research.
References & Further Reading
- Sharma N, Kukreja D, Giri T, Kumar S, Shah RP. Synthetic pharmaceutical peptides characterization by chromatography principles and method development. Journal of Separation Science. 2022;45(13):2200–2216. DOI: 10.1002/jssc.202101034. PMID: 35460196.
- Mant CT, Chen Y, Yan Z, Popa TV, Kovacs JM, Mills JB, Tripet BP, Hodges RS. HPLC analysis and purification of peptides. Methods in Molecular Biology. 2007. PMID: 18604941.
- Smith AJ. Amino acid analysis. Methods in Enzymology. 1997;289:419–426. DOI: 10.1016/S0076-6879(97)89057-X. PMID: 9353731.
- Højrup P. Analysis of Peptides and Conjugates by Amino Acid Analysis. Methods in Molecular Biology. 2015;1348:65–76. DOI: 10.1007/978-1-4939-2999-3_8. PMID: 26424264.
- Højrup P. Characterization of Synthetic Peptides by Mass Spectrometry. Methods in Molecular Biology. 2024. DOI: 10.1007/978-1-0716-3914-6_7. PMID: 38997482.
- Qasrawi DO, Petrotchenko EV, Borchers CH. Amino acid analysis for peptide quantitation using reversed-phase liquid chromatography combined with multiple reaction monitoring mass spectrometry. Analytical and Bioanalytical Chemistry. 2023;415(22):5261–5267. DOI: 10.1007/s00216-023-04840-2. PMID: 37468754.
- Woiwode U, et al. A Strategy for assessing peak purity of pharmaceutical peptides in reversed-phase chromatography methods using two-dimensional liquid chromatography coupled to mass spectrometry. Part II. 2023. PMID: 36871316.
- Raso SW, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharmaceutical Research. 2023;40(6):1317–1328. DOI: 10.1007/s11095-023-03493-1. PMID: 36949371.
Azyven Research — Research Today. A Healthier Tomorrow.
For laboratory research and analytical education only. Azyven Research materials are not for human or veterinary use.